Sai Life Sciences Limited (NSE:SAILIFE)
737.20
+5.70 (0.78%)
At close: Jun 6, 2025, 3:30 PM IST
Sai Life Sciences Revenue
In the fiscal year ending March 31, 2025, Sai Life Sciences had annual revenue of 16.95B INR with 15.66% growth. Sai Life Sciences had revenue of 5.80B in the quarter ending March 31, 2025, with 31.94% growth.
Revenue
16.95B
Revenue Growth
+15.66%
P/S Ratio
9.07
Revenue / Employee
5.41M
Employees
2,845
Market Cap
153.70B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 16.95B | 2.29B | 15.66% |
Mar 31, 2024 | 14.65B | 2.48B | 20.38% |
Mar 31, 2023 | 12.17B | 3.48B | 39.97% |
Mar 31, 2022 | 8.70B | 1.10B | 14.44% |
Mar 31, 2021 | 7.60B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sun Pharmaceutical Industries | 525.78B |
Divi's Laboratories | 93.60B |
Cipla | 271.45B |
Apollo Hospitals Enterprise | 217.94B |
Mankind Pharma | 122.07B |
Zydus Lifesciences | 232.42B |
Aurobindo Pharma | 317.24B |
Alkem Laboratories | 129.65B |